Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Efficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trials.

Karbasi-Afshar R, Aslani J, Ghanei M.

Caspian J Intern Med. 2014 Summer;5(3):130-6. Review.

PMID:
25202439
[PubMed]
Free PMC Article
2.

Effects of two chinese herbal formulae for the treatment of moderate to severe stable chronic obstructive pulmonary disease: a multicenter, double-blind, randomized controlled trial.

Wang G, Liu B, Cao Y, Du Y, Zhang H, Luo Q, Li B, Wu J, Lv Y, Sun J, Jin H, Wei K, Zhao Z, Kong L, Zhou X, Miao Q, Wang G, Zhou Q, Dong J.

PLoS One. 2014 Aug 13;9(8):e103168. doi: 10.1371/journal.pone.0103168. eCollection 2014.

PMID:
25118962
[PubMed - in process]
Free PMC Article
3.

p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice.

Marumo S, Hoshino Y, Kiyokawa H, Tanabe N, Sato A, Ogawa E, Muro S, Hirai T, Mishima M.

BMC Pulm Med. 2014 May 7;14:79. doi: 10.1186/1471-2466-14-79.

PMID:
24885161
[PubMed - in process]
Free PMC Article
4.

The Saudi Guidelines for the Diagnosis and Management of COPD.

Khan JH, Lababidi HM, Al-Moamary MS, Zeitouni MO, Al-Jahdali HH, Al-Amoudi OS, Wali SO, Idrees MM, Al-Shimemri AA, Al Ghobain MO, Alorainy HS, Al-Hajjaj MS.

Ann Thorac Med. 2014 Apr;9(2):55-76. doi: 10.4103/1817-1737.128843.

PMID:
24791168
[PubMed]
Free PMC Article
5.
6.

Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Gupta D, Agarwal R, Aggarwal AN, Maturu VN, Dhooria S, Prasad KT, Sehgal IS, Yenge LB, Jindal A, Singh N, Ghoshal AG, Khilnani GC, Samaria JK, Gaur SN, Behera D; S. K. Jindal for the COPD Guidelines Working Group.

Lung India. 2013 Jul;30(3):228-67. doi: 10.4103/0970-2113.116248.

PMID:
24049265
[PubMed]
Free PMC Article
7.

Randomized Trials Built on Sand: Examples from COPD, Hormone Therapy, and Cancer.

Suissa S.

Rambam Maimonides Med J. 2012 Jul 31;3(3):e0014. doi: 10.5041/RMMJ.10082. Print 2012 Jul.

PMID:
23908838
[PubMed]
Free PMC Article
8.

Oral huangqi formulae for stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Wu L, Chen Y, Xu Y, Guo X, Li X, Zhang AL, May BH, Xue CC, Wen Z, Lin L.

Evid Based Complement Alternat Med. 2013;2013:705315. doi: 10.1155/2013/705315. Epub 2013 Mar 27.

PMID:
23606889
[PubMed]
Free PMC Article
9.

Comparison of the variability of the annual rates of change in FEV₁ determined from serial measurements of the pre- versus post-bronchodilator FEV₁ over 5 years in mild to moderate COPD: results of the lung health study.

Tashkin DP, Wang HJ, Halpin D, Kleerup EC, Connett J, Li N, Elashoff R.

Respir Res. 2012 Aug 15;13:70. doi: 10.1186/1465-9921-13-70.

PMID:
22894725
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study.

Taylor-Robinson D, Whitehead M, Diderichsen F, Olesen HV, Pressler T, Smyth RL, Diggle P.

Thorax. 2012 Oct;67(10):860-6. doi: 10.1136/thoraxjnl-2011-200953. Epub 2012 May 3.

PMID:
22555277
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Lung function decline in COPD.

Tantucci C, Modina D.

Int J Chron Obstruct Pulmon Dis. 2012;7:95-9. doi: 10.2147/COPD.S27480. Epub 2012 Feb 9. Review.

PMID:
22371650
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Antioxidants of therapeutic relevance in COPD from the neotropical blueberry Anthopterus wardii.

Flores G, Dastmalchi K, Dabo AJ, Whalen K, Pedraza-Peñalosa P, Foronjy RF, D'Armiento JM, Kennelly EJ.

Food Chem. 2012 Mar 1;131(1):119-125.

PMID:
22363097
[PubMed]
Free PMC Article
13.

Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations.

Field SK.

Clin Med Insights Circ Respir Pulm Med. 2011;5:57-70. doi: 10.4137/CCRPM.S7049. Epub 2011 Oct 18. Erratum in: Clin Med Insights Circ Respir Pulm Med. 2012;6:51.

PMID:
22084617
[PubMed]
Free PMC Article
14.

Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.

Franssen FM, Spruit MA, Wouters EF.

Int J Chron Obstruct Pulmon Dis. 2011;6:493-501. doi: 10.2147/COPD.S24443. Epub 2011 Sep 26.

PMID:
22069360
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?

Akamatsu K, Matsunaga K, Sugiura H, Koarai A, Hirano T, Minakata Y, Ichinose M.

Front Pharmacol. 2011 Jul 18;2:36. doi: 10.3389/fphar.2011.00036. eCollection 2011.

PMID:
21811461
[PubMed]
Free PMC Article
16.

Inhibition of granulocyte migration by tiotropium bromide.

Vacca G, Randerath WJ, Gillissen A.

Respir Res. 2011 Feb 27;12:24. doi: 10.1186/1465-9921-12-24.

PMID:
21352583
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Association between lung function and exacerbation frequency in patients with COPD.

Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Mölken MR.

Int J Chron Obstruct Pulmon Dis. 2010 Dec 9;5:435-44. doi: 10.2147/COPD.S13826. Review.

PMID:
21191438
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Nebulized corticosteroids in the management of acute exacerbation of COPD.

Gaude GS, Nadagouda S.

Lung India. 2010 Oct;27(4):230-5. doi: 10.4103/0970-2113.71957.

PMID:
21139721
[PubMed]
Free PMC Article
19.

Update on the management of chronic obstructive pulmonary disease.

Maas AK, Mannino DM.

F1000 Med Rep. 2010 Oct 12;2. pii: 72. doi: 10.3410/M2-72.

PMID:
20948828
[PubMed]
Free PMC Article
20.

Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease.

Marwick JA, Chung KF.

Int J Chron Obstruct Pulmon Dis. 2010 Sep 7;5:297-309. Review.

PMID:
20856829
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk